Clinical Trial Update: Optimal MTX Dose With Folic Acid Randomized Case-control Trial [Phase 4]

View source ↗

Summary

Phase 4 randomized case-control trial evaluating the optimal methotrexate dose with folic acid in rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• METHOTREXATE (METHOTREXATE)
• folic acid (folic acid)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Rheumatoid Arthritis | Phase 4 | Status: UNKNOWN